Gels Based for Drug Delivery System

A special issue of Gels (ISSN 2310-2861). This special issue belongs to the section "Gel Applications".

Deadline for manuscript submissions: 30 April 2024 | Viewed by 1836

Special Issue Editors


E-Mail Website
Guest Editor
Drug Delivery Research Laboratory, Department of Pharmaceutical Sciences, Dr. H. S. Gour University (A Central University), Sagar 470003, MP, India
Interests: nanobiotechnology; nano drug and bioactive delivery; vaccine development and delivery; smart-material-based nano-delivery system

E-Mail Website
Guest Editor
Institut Charles Sadron, UPR 22, CNRS-Université de Strasbourg, 23 rue du Loess, BP 84047, 67034 Strasbourg, France
Interests: thermoreversible gelation of polymers and biopolymers; organogels; polymer-solvent compounds; self-assembled systems; hybrid gels; neutron scattering; calorimetry; rheology
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

In recent years, novel drug delivery systems have proven very adept at delivering therapeutic molecules with site-specific and localized effects. Novel gels are capable of controlled and sustained release of loaded therapeutic molecules.  This Special Issue will cover all the latest research and develop new ideas and research directions. The issue will cover all types of gels with their drug release potentials and applications. Smart gels and biodegradable,and erodable, hydrogels can be developed which respond to biological and external stimuli, such as temperature, pH, chemical, enzymes, electrical, light, antigens, etc. Technically all the routes can be exploited for the bioactive delivery via gel-based drug delivery system viz. hydrogels and emulgels as vaginal drug delivery systems, in situ gels as nasal drug delivery systems, cubic phase gels drug delivery systems, ocular, topical. The bioadhesive films formed from organic–inorganic hybrid gels possessed very good qualities for application on the skin and may provide a promising formulation for TDDS, especially when the patient acceptability from an aesthetic perspective of the dosage form is a prime consideration. Furthermore, the possibility of using various routes such as oral, buccal, transdermal, intravenous, and gene delivery further diversify their applications in the biomedical field. The use of natural gums/polymers to possess floating or mucoadhesive properties in the gastric system for the benefit of increasing gastric resident time and to improve therapeutic efficacy, particularly those drugs are having narrow therapeutic index. Bigel system usually result from mixing a hydrogel and an organogel are exploited for their composition and unique structure which confer promising drug delivery attributes, such as mucoadhesion, the ability to control drug release, and the possibility of including both hydrophilic and lipophilic drugs in the same system. Research in other fields, such as cosmetics and food technology, has also served as useful tools for the manufacture of, and insight into, drug delivery bigels. Buccal and vaginal bigels have emerged as alternative options, thus increasing the potential applications of these dosage forms as drug delivery systems. Oleogels are another gel-based drug delivery system that are oil-structured that are made from a gelling agent added to an edible oil. Fluid gel is a suspension of gel particles and widely used in food industry but a comprehensive analysis of fluid gel applications as drug delivery systems and formulations with specific functions will provide insight into their potential pharmaceutical applications and, provide new strategies for developing feasible pharmaceuticals for specific needs. Aerogel, as a typical porous material, has the characteristics of extremely low density, low thermal conductivity, high specific surface area and high porosity. aerogel can be used as a drug carrier and has great development potential in the field of biomedicine. novel organogel based lyotropic liquid crystals (LLC) were prepared and investigated as controlled release matrices.

Prof. Dr. Suresh P. Vyas
Prof. Dr. Jean-Michel Guenet
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Gels is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • biodegradable
  • bioadhesive
  • organogel
  • smart gel
  • modified release

Published Papers (1 paper)

Order results
Result details
Select all
Export citation of selected articles as:

Review

19 pages, 10996 KiB  
Review
Hydrogel-Based Therapy for Age-Related Macular Degeneration: Current Innovations, Impediments, and Future Perspectives
by Chengzhi Zhang, Jiale Wang, Hao Wu, Wenhui Fan, Siyu Li, Dong Wei, Zongming Song and Ye Tao
Gels 2024, 10(3), 158; https://doi.org/10.3390/gels10030158 - 21 Feb 2024
Viewed by 1490
Abstract
Age-related macular degeneration (AMD) is an ocular disease that leads to progressive photoreceptor death and visual impairment. Currently, the most common therapeutic strategy is to deliver anti-vascular endothelial growth factor (anti-VEGF) agents into the eyes of patients with wet AMD. However, this treatment [...] Read more.
Age-related macular degeneration (AMD) is an ocular disease that leads to progressive photoreceptor death and visual impairment. Currently, the most common therapeutic strategy is to deliver anti-vascular endothelial growth factor (anti-VEGF) agents into the eyes of patients with wet AMD. However, this treatment method requires repeated injections, which potentially results in surgical complications and unwanted side effects for patients. An effective therapeutic approach for dry AMD also remains elusive. Therefore, there is a surge of enthusiasm for the developing the biodegradable drug delivery systems with sustained release capability and develop a promising therapeutic strategy. Notably, the strides made in hydrogels which possess intricate three-dimensional polymer networks have profoundly facilitated the treatments of AMD. Researchers have established diverse hydrogel-based delivery systems with marvelous biocompatibility and efficacy. Advantageously, these hydrogel-based transplantation therapies provide promising opportunities for vision restoration. Herein, we provide an overview of the properties and potential of hydrogels for ocular delivery. We introduce recent advances in the utilization of hydrogels for the delivery of anti-VEGF and in cell implantation. Further refinements of these findings would lay the basis for developing more rational and curative therapies for AMD. Full article
(This article belongs to the Special Issue Gels Based for Drug Delivery System)
Show Figures

Figure 1

Back to TopTop